DUBLIN, Ireland, and VIENNA, Austria: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Aelian Biotechnology (“Aelian”) today announced the signing of a license agreement granting Aelian access to ERS Genomics' CRISPR/Cas9 patent portfolio, to support Aelian's commercial functional genomic screening platform.  Aelian [...]

Nottingham, UK: The new Inhaled Dissolution Dose Collector (IDDC) from Copley Scientific is a flexible, easy-to-use system for collecting the respirable fraction of the dose delivered by a metered dose or dry powder inhaler (MDI or DPI) for dissolution testing. The dissolution profile of inhaled drugs underpins therapeutic efficacy and is an area of increasing [...]

New Center of Excellence to Advance Highly Multiplexed Tissue Imaging in Translational and Clinical Cancer Research SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will establish a new Center of Excellence (CoE) for Imaging Mass Cytometry™ at Georgetown [...]

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm (Nasdaq:FLDM) today announced that Covance, the drug development business of LabCorp® (NYSE: LH), a leading global life sciences company, has selected Fluidigm’s CyTOF® technology and the industry-leading Maxpar® Direct™ Immune Profiling Assay™ to develop highly multiplexed immune profiling services. Setting an industry first, high-multiplex mass cytometry enables clinical researchers to simultaneously profile [...]

DUBLIN, Ireland - ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property held by Dr. Emmanuelle Charpentier, announced today that the European Patent Office (EPO) has rejected arguments filed in opposition to European patent No. EP2800811 jointly held by Dr. Charpentier, the Regents of the University of California, and [...]

GHENT, Belgium -- PharmaFluidics NV, an innovative player in the field of analytical chromatography, announces a product range extension into capillary flow rate liquid chromatography (capillary LC). PharmaFluidics initiates commercial supplies of its new µPAC™ capLC column, bringing unprecedented sensitivity, reproducibility and robustness to a new range of customers worldwide, including the biopharmaceutical industry. PharmaFluidics' unique [...]

NEW YORK-- Schrödinger, Inc. (the “Company”) (Nasdaq: SDGR), whose differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications, today announced the closing of its initial public offering of 13,664,704 shares of common stock at a public offering price of $17.00 per share, which includes 1,782,352 additional shares of [...]

NEW YORK -- Enzo Biochem, Inc. (NYSE:ENZ) (the “Company”) today disclosed that Harbert Discovery Fund, LP (“Harbert”) filed a lawsuit against the Company and the members of its board of directors (“Board”) in the U.S. District Court for the Southern District of New York. Enzo commented as follows: “We are disappointed but not surprised by [...]

Vironova has received the world’s first and only GMP certification for Electron Microscope Lab from Swedish Medical Products Agency (Stockholm) – Vironova AB (publ), the pioneer in empowering new biopharma drug development and quality control by using advanced electron microscopy, has received a certificate of GMP compliance of a manufacturer from the Swedish Medical Products [...]

Dr. Denis Zaccarin Succeeds Phillips to Lead Research and Development MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that Michael Phillips has decided to retire from his role as the company’s Senior Vice President of Research and Development as of [...]